Fidelity SPDR Advertisement
Home > Boards > Free Zone > Health and Sciences > Biotech Values

HEB’s insiders are looting the company:

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
DewDiligence Member Profile
Member Level 
Followed By 480
Posts 81,006
Boards Moderated 22
Alias Born 09/05/02
160x600 placeholder
U.S. Stocks Skid; Manufacturing Slows Down
U.S. stock investors continued their selling ways this week, pushing prices lower in early trading. Wednesday's slide stemmed from upbeat employment and manufacturing data for September, which although points to positive momentum for the U.S. economy, continued to fuel worries that the Federal Reserve may raise interest rates sooner than later.
Top Equities Stories Of The Day
JAL Customer Data Target of Cyber Attack
IPO Scorecard: Update on Selected Initial Stock Offerings
J.P. Morgan Expects $869 Million Credit for Mortgage Actions
Intel Invests in Chinese Chip Maker -- Update
Bank Branches in U.S. Decline to Lowest Level Since 2005
Private Payrolls Increased by 213,000 Jobs in September
Starboard Pushes For Potential Yahoo-AOL Tie-Up -- 5th Update
Correction to Dow Index Overseers Correction
DewDiligence Member Level  Tuesday, 06/02/09 06:08:42 PM
Re: exwannabe post# 78906
Post # of 182338 
HEB’s insiders are looting the company:

While pumpers are mindlessly pumping HEB on various message boards, officers and directors have been engaged in a game of their own: systematically looting the company to the greatest extent possible. Last week, without even waiting for FDA action on the Ampligen BLA, HEB paid the CEO a $300K bonus and the CMO a $150K bonus (#msg-38179694).

The BoD had the audacity to grant these bonuses despite the fact that HEB cut the salaries of its non-executive employees in Jan 2009. Despite the fact that the CEO received more than $1M in compensation in 2008. Despite the fact that the CEO received almost $3M in compensation in 2007.

Want more? HEB pays each non-employee director $150K per annum merely to attend board meetings! You can find these and other details in the recent DEF14A filing: http://sec.gov/Archives/edgar/data/946644/000114420409029059/v150612_def14a.htm .

I shudder to think how much insiders will pay themselves if by some miracle the FDA actually approves Ampligen.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist